HRV Pharma unveils India's first AI-native pharmaceutical operating system RIKO™

image credit- freepik

Hyderabad-based HRV Pharma, the global, virtual pharmaceutical company, has announced the launch of RIKO™, a reasoning engine developed from the company's own operating history across the pharmaceutical value chain.

The self-learning intelligent pharma operating system is a first-of-its-kind, conceptualised in-house and built on millions of proprietary pharmaceutical decisions made within HRV’s network of over 50 FDA and EU-GMP certified manufacturing partners & customers spanning 55 countries.

The platform evaluates chemistry risk, nitrosamine potential, supplier reliability, regulatory history, manufacturing capability, commercial alignment, and market signals simultaneously, before a sourcing commitment or licensing decision is finalized on both sides of the pharma manufacturing chain.

For manufacturing partners, the platform replaces slow, paperwork-heavy qualification cycles with a faster, more transparent path to being matched against live inquiries.

For customers and licensing partners, the platform means risk is surfaced and addressed before a molecule or a supply agreement is committed to, rather than discovered after an audit or a market complaint.